LOGIN  |  REGISTER
Recursion

Recent Insider Transactions - Relmada Therapeutics (NASDAQ: RLMD)

Follow NASDAQ:RLMD Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ RLMD Relmada Therapeutics
Ence Chuck / officer: CA and CO
06/26/2025
Buy
$0.67
400,000
$268K
400,000
NASDAQ RLMD Relmada Therapeutics
Shenouda Maged / officer: Chief Financial Officer
06/26/2025
Buy
$0.67
600,000
$402K
600,000
NASDAQ RLMD Relmada Therapeutics
TRAVERSA SERGIO / director, officer: Chief Executive Officer
06/26/2025
Buy
$0.67
800,000
$536K
800,000
NASDAQ RLMD Relmada Therapeutics
CASAMENTO CHARLES J / director
06/26/2025
Buy
$0.67
100,000
$67K
100,000
NASDAQ RLMD Relmada Therapeutics
GLASSPOOL JOHN / director
06/26/2025
Buy
$0.67
100,000
$67K
100,000
NASDAQ RLMD Relmada Therapeutics
Fedeli Fabiana / director
06/26/2025
Buy
$0.67
100,000
$67K
100,000
NASDAQ RLMD Relmada Therapeutics
Kelly Paul Edward / director, officer: Chief Operating Officer
06/26/2025
Buy
$0.67
400,000
$268K
400,000
NASDAQ RLMD Relmada Therapeutics
Kelly Paul Edward / director, officer: Chief Operating Officer
05/16/2025
Buy
$0.43
200,000
$86K
412,295
NASDAQ RLMD Relmada Therapeutics
Shenouda Maged / officer: Chief Financial Officer
05/20/2025
Buy
$0.52
60,000
$31K
288,335
NASDAQ RLMD Relmada Therapeutics
Shenouda Maged / officer: Chief Financial Officer
05/19/2025
Buy
$0.49
90,000
$44K
228,335
NASDAQ RLMD Relmada Therapeutics
Shenouda Maged / officer: Chief Financial Officer
05/16/2025
Buy
$0.44
50,000
$22K
138,335
NASDAQ RLMD Relmada Therapeutics
Ence Chuck / officer: CA and CO
05/16/2025
Buy
$0.45
228,961
$103K
267,931
NASDAQ RLMD Relmada Therapeutics
TRAVERSA SERGIO / director, officer: Chief Executive Officer
05/20/2025
Buy
$0.56
147,686
$82K
734,024
NASDAQ RLMD Relmada Therapeutics
TRAVERSA SERGIO / director, officer: Chief Executive Officer
05/19/2025
Buy
$0.50
30,000
$15K
586,338
NASDAQ RLMD Relmada Therapeutics
TRAVERSA SERGIO / director, officer: Chief Executive Officer
05/16/2025
Buy
$0.45
172,314
$77K
556,338

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous